Advisories For Registrants
June 17th, 2024
Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection site
June 10th, 2024
Important Safety and Efficacy Information on ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) – Market Withdrawal and Continued Restricted Access
June 6th, 2024
Importation of USA-authorized Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg due to the current shortage of Canadian-authorized carbamazepine
Advisories For The Public
August 5th, 2024
Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks
August 5th, 2024
JAMP Digoxin 0.0625 mg and 0.125 mg tablets recalled due to possible incorrect dose, which may pose health risks
July 29th, 2024
Various multivitamins and supplements distributed across Canada are being recalled because they may contain metal fibres
July 26th, 2024
Incorrect dosing information on the “SAVE ME” instructional card in the Naloxone Take Home Kit by Canadian Hospital Specialties Ltd
June 17th, 2024
Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection site
June 10th, 2024
Accel-Ondansetron ODT, Mint-Betahistine and PMS-Pirfenidone tablets recalled due to data integrity concerns
30-Day Medication Supply Update
Easing away from the 30-day medication supply recommendation over the next two weeks
News release
May 4, 2020 – St. John’s, NL – Newfoundland & Labrador Pharmacy Board
On March 19, 2020, the Newfoundland & Labrador Pharmacy Board (NLPB) provided guidance to pharmacists and the public that a 30-day supply of medication was recommended in order to protect the public’s health interest as we proceed through the COVID-19 pandemic. This temporary measure was made purely in the best interest of the public’s health and safety. NLPB is pleased to report that due to a nationwide effort to protect drug supply, medication inventories appear to be stabilizing and returning to pre-pandemic quantities. Over the next two weeks, the 30-day supply recommendation is being eased away from on condition that pharmacists have the supply they need on hand to provide patients with a longer days’ supply; it is important to note that some restrictions may still apply depending on specific drug shortages that occur.
Part of the ongoing assessment NLPB has been doing surrounding the 30-day supply recommendation has been based on information received from regular meetings with Health Canada, drug manufacturers associations and distributors. At this point in time, information suggests that the national drug supply is stabilizing and will continue to improve over the next two to four weeks.
Patients’ best interests remain our number one priority. In collaboration with the Pharmacists’ Association of Newfoundland & Labrador (PANL) and other healthcare partners we have decided to ease away from the 30-day supply recommendation over the next two weeks.
“Thank you for your patience and understanding surrounding the 30-day supply recommendation,” says NLPB Registrar Margot Priddle. “We are aware of the challenges that accompanied this tough and temporary decision but it was a vital measure taken nationally to protect access to necessary medications for Newfoundlanders and Labradorians.”
While the 30-day supply recommendation is diminishing, NLPB will continue to closely monitor drug supply and the overall healthcare environment associated with this pandemic and will respond accordingly should access to medications become compromised.
What this means for patients:
|
-30-
Media Contacts:
Amanda Martin | Communications Specialist
Newfoundland & Labrador Pharmacy Board
709.753.5877 ext. 107
amartin@nlpb.ca
About the Newfoundland & Labrador Pharmacy Board
The Newfoundland & Labrador Pharmacy Board continues to build on over 100 years of pharmacy practice regulation within Newfoundland & Labrador. Our actions are carefully made in accordance with our mandate to protect the public’s health interest within the province.
Visit nlpb.ca and follow @nlpharmacyboard on Facebook and Twitter
